Gourlay Terence, Shedden Laurie, Horne David, Stefanou Demetrios M
Bioengineering Unit, University of Strathclyde, Glasgow, Scotland.
Perfusion. 2010 Jan;25(1):31-9. doi: 10.1177/0267659110361997. Epub 2010 Feb 16.
The use of Di-2-ethylhexyl phthalate (DEHP) plasticised polyvinyl chloride (DEHPPPVC) in medical devices persists despite evidence suggesting that DEHP migration can be harmful. Researchers have shown that a simple surface sulfonation process can retard the migration of DEHP, which may reduce the associated inflammatory response. The present study is designed to investigate the effects of surface sulfonation on DEHP migration and blood contact activation using in vitro and rodent models.
The study was carried out in two phases: phase 1, in which the migration rate of DEHP from DEHPPPVC and sulfonated DEHP plasticised PVC (SDEHPPPVC) was measured; phase 2 of the study, in which the materials were incorporated into a rat recirculation biomaterial test model and blood samples taken to assess CD11b expression on neutrophils, IL-6 and Factor XIIa.
The initial DEHP concentration washed from the surface after storage was 37.19 +/- 1.17 mg/l in the PPVC group and 5.89 +/- 0.81 mg/l in the SPPVC group (p<0.0001). The post-wash migration rate was 3.07 +/- 0.32 mg/l/hour in the PPVC group compared to 0.46 +/- 0.038 mg/l/hour in the SPPVC group (p<0.0001). In phase 2 of the study, CD11b expression increased by 228.9% +/- 37% over the test period in the PPVC group compared to 118.3% +/- 46% in the SPPVC group (p<0.01). IL-6 levels rose from 3.1 +/- 1.4 pg/ml to 263 +/- 26 pg/ml in the PPVC group and 2.2 +/- 1.6 pg/ml to 161 +/- 29 pg/ml in the SPPVC group (p<0.01). Factor XIIa levels rose from 0.22 +/- 0.13 g/ml to 3.7 +/- 0.32 microg/ml and 0.28 +/- 0.09 to 2.71 +/- 0.21 microg/ml in the PPVC and SPPVC groups, respectively (p<0.05 at 90 minutes).
The simple sulfonation process significantly retards the migration of DEHP and is associated with the moderation of contact activation processes.
尽管有证据表明邻苯二甲酸二(2-乙基己基)酯(DEHP)增塑的聚氯乙烯(DEHP-PVC)在医疗器械中的使用存在危害,但这种材料仍在持续使用。研究人员表明,一种简单的表面磺化工艺可以延缓DEHP的迁移,这可能会减少相关的炎症反应。本研究旨在使用体外和啮齿动物模型研究表面磺化对DEHP迁移和血液接触激活的影响。
该研究分两个阶段进行:第一阶段,测量DEHP从DEHP-PVC和磺化DEHP增塑PVC(SDEHP-PVC)中的迁移率;研究的第二阶段,将材料纳入大鼠再循环生物材料测试模型,并采集血样以评估中性粒细胞上CD11b的表达、白细胞介素-6(IL-6)和凝血因子XIIa。
储存后从表面洗脱的初始DEHP浓度在PPVC组中为37.19±1.17mg/l,在SPPVC组中为5.89±0.81mg/l(p<0.0001)。洗脱后的迁移率在PPVC组中为3.07±0.32mg/l/小时,而在SPPVC组中为0.46±0.038mg/l/小时(p<0.0001)。在研究的第二阶段,与SPPVC组的118.3%±46%相比,PPVC组在测试期间CD11b表达增加了228.9%±37%(p<0.01)。IL-6水平在PPVC组中从3.1±1.4pg/ml升至263±26pg/ml,在SPPVC组中从2.2±1.6pg/ml升至161±29pg/ml(p<0.01)。凝血因子XIIa水平在PPVC组和SPPVC组中分别从0.22±0.13μg/ml升至3.7±0.32μg/ml和从0.28±0.09升至2.71±0.21μg/ml(90分钟时p<0.05)。
简单的磺化工艺显著延缓了DEHP的迁移,并与接触激活过程的减轻有关。